Kiara Health (Pty) Ltd is proud to have been chosen as the partner, in select SSA markets, to Shin Poong Pharmaceutical Co. Ltd., South Korea, for the marketing and distribution of their WHO prequalified artesunate-pyronaridine (AS-PY) fixed-dose antimalarial combination, co-developed with Medicines for Malaria Venture (MMV).
Oliva Komane, a veteran in the Pharmaceutical Industry, celebrates a career spanning 30 Years on the 1st of February 2021.
Dipesh Daya was born in Johannesburg and raised in Lenasia. He completed his schooling in Lenasia in 2003 and graduated […]
The acquisition by Kiara Health of a multinational pharmaceutical manufacturing facility, sold to fulfil a need for transformation in the local pharmaceutical sector, sees the dawn of a new type of pharmaceutical company that offers an end-to-end solution along the patient journey.
Pan-African pharmaceutical company, Kiara Health, has kicked off its Industry 4.0 journey, partnering with Datacentrix, a high performing and secure ICT solutions provider.
Cardiac arrhythmias are very common but underdiagnosed due to their transient and asymptomatic nature.
Effective August 2020, Imperial acquired a 49% shareholding in Pharmafrique (Pty) Ltd (trading as Kiara Health).
– Lead Contributor, Dr Skhumbuzo Ngozwana, August 2019.
Tuesday, 3 July 2018 Young pan-African pharmaceutical company, Kiara Health, has been awarded the coveted Africa Visionary Innovation